Business Context and Reporting Period
This Form 8-K Current Report was filed by Herbalife Nutrition Ltd. on December 27, 2022, covering events occurring on December 22, 2022. The filing primarily addresses the formal appointment of Michael O. Johnson as Chief Executive Officer (CEO) and the terms of his employment agreement.
Key Financial Metrics
This filing does not contain revenue, profit, cash flow, margin, debt, or liquidity metrics. It focuses exclusively on executive compensation and equity awards.
- Base Salary: $1 per annum.
- Signing Bonus: $250,000.
- Target Annual Bonus: $1,200,000 (Maximum opportunity: $2,400,000), payable in common shares.
- Equity Incentive Award (Grant Date Fair Value): $10,000,000.
- Equity Composition: 50% time-based stock units (RSUs) and 50% stock appreciation rights (SARs).
- RSU Grant: 346,020 units.
- SAR Grant: 783,699 rights with a base price of $14.45 per share.
Material Changes
The primary material change is the transition of Michael O. Johnson from Interim CEO to permanent CEO. This change is accompanied by a new employment agreement with a term through December 31, 2023, and the issuance of significant equity awards under the Company's 2014 Stock Incentive Plan.
Outlook, Risks, and Unusual Items
Management Commentary: The filing confirms the Board's decision to appoint Mr. Johnson as the non-interim CEO. A press release issued on December 27, 2022, is attached as an exhibit.
Compensation Risks and Vesting Conditions:
- Voluntary Resignation: If Mr. Johnson resigns without a successor being appointed, unvested equity awards are forfeited.
- Succession Scenarios: If a new non-interim CEO is appointed before the first anniversary and Mr. Johnson remains on the Board, 50% of the SARs are forfeited, and RSU vesting continues based on Board service. If the appointment occurs after the first anniversary, all unvested awards remain outstanding subject to Board service.
- Termination Without Cause: Triggers immediate full vesting of RSUs and pro-rata vesting of SARs, subject to the execution of a general release of claims.
- Change in Control: Involuntary termination within 24 months of a change in control triggers acceleration of equity awards.
- Severance: Mr. Johnson is not eligible for the Executive Officer Severance Plan.
Investor Verification Checklist
- Verify the full text of the CEO Employment Agreement (Exhibit 10.1) for detailed definitions of "cause" and "change in control."
- Review the Stock Unit Award Agreement (Exhibit 10.2) and Stock Appreciation Right Award Agreement (Exhibit 10.3) for specific vesting schedules and performance conditions.
- Confirm the impact of the $10 million equity grant on future dilution and share count.
- Monitor the press release (Exhibit 99.1) for any additional strategic context regarding the leadership transition.